Shawn Singh Insider Trading $VTGN VistaGen Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Shawn Singh.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Shawn Singh. Shawn Singh is President (Interim) in Echo Therapeutics, Inc. ($SONT) and CHIEF EXECUTIVE OFFICER in VistaGen Therapeutics, Inc. ($NA).
Shawn Singh in VistaGen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shawn Singh: CHIEF EXECUTIVE OFFICER
Holdings: 40,375 shares
Current Value: $121,933
Latest Transaction: Apr 27 2021
$VTGN Market Capitalization: $23.38M
$VTGN Previous Close: $3.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Shawn Singh in VistaGen Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 5,000 | 7,500 | 0 | |
| Apr 27 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 5,000 | 7,500 | 40,375 | 35.4 K to 40.4 K (+14.13 %) |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.77 | 300,000 | 531,000 | 300,000 | |
| Jan 04 2021 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 0.45 | 5,000 | 2,261 | 35,375 | 30.4 K to 35.4 K (+16.46 %) |
| Jul 01 2020 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 0.45 | 5,000 | 2,240 | 30,375 | 25.4 K to 30.4 K (+19.70 %) |
| Apr 27 2020 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 0.40 | 300,000 | 119,400 | 300,000 | |
| Oct 22 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.41 | 300,000 | 423,000 | 300,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.00 | 170,000 | 170,000 | 170,000 | |
| May 28 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.00 | 80,000 | 80,000 | 80,000 | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 3,000 | 4,500 | 0 | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 1,125 | 1,688 | 0 | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | M | 1.50 | 21,250 | 31,875 | 0 | |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 3,000 | 4,500 | 25,375 | 22.4 K to 25.4 K (+13.41 %) |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 1,125 | 1,688 | 22,375 | 21.3 K to 22.4 K (+5.29 %) |
| Jan 15 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Buy | M | 1.50 | 21,250 | 31,875 | 21,250 | 0 to 21.3 K |
| Jan 14 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.70 | 220,000 | 374,000 | 220,000 | |
| Jan 14 2019 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.70 | 220,000 | 374,000 | 220,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 175,000 | 262,500 | 175,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 1.96 | 175,000 | 343,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 100,000 | 150,000 | 100,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.80 | 100,000 | 380,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 200,000 | 300,000 | 200,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 3.49 | 200,000 | 698,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 5,000 | 7,500 | 5,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 5,000 | 50,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 21,250 | 31,875 | 21,250 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 21,250 | 212,500 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 50,000 | 75,000 | 50,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 50,000 | 500,000 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 1,125 | 1,688 | 1,125 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 1,125 | 11,250 | 0 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.50 | 3,000 | 4,500 | 3,000 | |
| Aug 31 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 3,000 | 30,000 | 0 | |
| Feb 05 2018 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.16 | 300,000 | 348,000 | 300,000 | |
| Sep 20 2017 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.56 | 125,000 | 195,000 | 125,000 | |
| Apr 28 2017 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 1.96 | 175,000 | 343,000 | 175,000 | |
| Nov 10 2016 | VTGN | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.80 | 100,000 | 380,000 | 100,000 | |
| Jun 21 2016 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 3.49 | 200,000 | 698,000 | 200,000 | |
| Feb 16 2016 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 20.00 | 5,000 | 100,000 | 0 | |
| Feb 16 2016 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 2,500 | 25,000 | 0 | |
| Feb 16 2016 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Grant | A | 0.00 | 5,625 | 0 | 26,234 | 20.6 K to 26.2 K (+27.29 %) |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 7.00 | 250,000 | 1,750,000 | 250,000 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 9.25 | 250,000 | 2,312,500 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 7.00 | 150,000 | 1,050,000 | 150,000 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 150,000 | 1,500,000 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 7.00 | 72,000 | 504,000 | 72,000 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 12.80 | 72,000 | 921,600 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 7.00 | 1,786 | 12,502 | 1,786 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 1,786 | 17,860 | 0 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 7.00 | 4,017 | 28,119 | 4,017 | |
| Nov 13 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | D | 10.00 | 4,017 | 40,170 | 0 | |
| Sep 03 2015 | NA | VistaGen Therapeut ... | Singh Shawn | CHIEF EXECUTIVE OFF ... | Option Exercise | A | 9.25 | 250,000 | 2,312,500 | 250,000 |
Page: 1